Srpski arhiv za celokupno lekarstvo 2012 Volume 140, Issue 9-10, Pages: 583-588
https://doi.org/10.2298/SARH1210583M
Full text ( 196 KB)
Changes in parameters of glycoregulation in gestational diabetes mellitus patients with different approach to insulin therapy introduction
Mladenović Violeta (Centar za endokrinologiju, dijabetes i bolesti metabolizma, Interna klinika, Klinički centar, Kragujevac)
Đukić Aleksandar (Centar za endokrinologiju, dijabetes i bolesti metabolizma, Interna klinika, Klinički centar, Kragujevac)
Varjačić Mirjana (Ginekološko-akušerska klinika, Klinički centar, Kragujevac)
Macut Đuro (Klinika za endokrinologiju, dijabetes i bolesti metabolizma, Klinički centar Srbije, Beograd)
Introduction. Gestational diabetes mellitus (GDM) is defined as any degree of
glucose intolerance with onset or first recognition during pregnancy. The
diagnosis of GDM is made by performing the oral glucose tolerance test (OGTT)
in women with risk factors, usually during 24th to 28th week of gestation.
The most common used insulin therapy regime is a conventional intensive
insulin therapy with four daily doses. Objective. The aim of our study was to
determine the changes in parameters of glycoregulation in GDM patients with
different approach to the introduction of insulin therapy. Methods. Study
group consisted of 50 pregnant women divided into two groups depending on the
parameters of glycoregulation (glycemic profile and HbA1). Group 1 consisted
of pregnant women initially treated with diet only and then, according to
glycemic profile and HbA1 profile, in the next few weeks with insulin
therapy. Group 2 were pregnant women who were treated with insulin therapy
immediately after GDM diagnosis. Results. There was a statistically
significant difference in mean glycemia values in the 60th and 120th minute
between the two groups (p=0.001). There was a difference in mean value of
fasting blood and postprandial glucose between the two groups; it was higher
in Group 2. There was a statistically significant difference between the two
groups in HbA1c value at the beginning (5.1±0.4% vs. 5.42±0.43%, p=0.005) and
at the end of therapy (4.87±0.29% vs. 5.1±0.39 %, p=0.018). Conclusion.
Satisfactory glycoregulation was achieved in both studied groups.
Keywords: gestational diabetes, parameters of glycoregulation, insulin therapy